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Abstract
Purpose Unicompartmental knee replacement (UKR) is widely considered to be a pre-total knee replacement (TKR) par-
ticularly in the young. The implication of this is that it is sensible to do a UKR, even though it will be revised at some stage, 
as it will delay the need for a TKR. The chance of a UKR being revised during a patient’s life time has not previously been 
calculated. The aim of this study was to estimate this lifetime revision risks for patients of different ages undergoing UKR.
Methods Calculations were based on data from a designer series of 1000 medial Oxford UKR with mean 10-year follow 
up. These UKR were implanted for the recommended indications using the recommended surgical technique. Parametric 
survival models were developed for patients of different ages based on observed data, and were extrapolated using a Markov 
model to estimate lifetime revision risk.
Results The estimated lifetime revision risk reduced with increasing age at surgery. Lifetime revision risk at age 55 was 15% 
(95% CI 12–19), at 65 it was 11% (8–13), at 75 it was 7% (5–9), and at 85 it was 4% (3–5).
Conclusion Provided UKR is used appropriately, the lifetime revision risk is markedly lower than expected. UKR should be 
considered to be a definitive knee replacement rather than a Pre-TKR even in the young. These lifetime estimates, alongside 
established benefits for UKR in speed of recovery, morbidity, mortality and function, can be discussed with appropriate 
patients when considering whether to implant a UKR or TKR.
Level of evidence III.
Keywords Lifetime revision risk · Unicompartmental knee replacement · Arthroplasty · Complications
Introduction
Clear communication of risks and benefits of proposed 
interventions are required for patients to make educated 
decisions, and to provide informed consent. Patients tend 
to have difficulty interpreting revision rates. The chance of 
having a revision during their lifetime is a simpler notion 
that is likely to be preferred by patients when communicat-
ing risk [9]. Lifetime revision risk can be expected to be 
highly dependent on an individual’s age at surgery. Life-
time risk of revision at different ages has been estimated 
for total knee replacement (TKR). About half of patients 
needing knee replacement can potentially be treated with 
either TKR or UKR [13, 41], and the decision as to which is 
most appropriate depends, in part, on revision rates. UKR is 
widely considered to be a pre-TKR [30, 35]. The implication 
of this is that it may be sensible to do a UKR, even though 
it will be revised at some stage, as it will delay the need 
for a TKR. As a result many patients, particularly younger 
ones, are counselled to expect a revision in their lifetime. For 
patients to decide whether to have a UKR or TKR it would 
therefore be helpful for them to know their lifetime risk of 
having a revision if they had a UKR. Currently the lifetime 
revision risk for UKR is not known.
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The evidence from large matched studies is that UKR 
provides a faster recovery [7], lower morbidity and mortality 
[19], return to work quicker [18], better function and bet-
ter satisfaction [20, 38, 41] than TKR. However, UKR are 
reported in national registries as having a higher revision 
rate [24–27]. In contrast, multiple long-term series published 
by those using mobile-bearing medial UKR, with the recom-
mended evidence-based indications and surgical techniques, 
report revision rates comparable with TKR [1, 22, 23, 31, 
33, 39, 42]. The main indication for medial UKR is antero-
medial osteoarthritis, in which there is bone-on-bone arthri-
tis medially, full thickness cartilage laterally and function-
ally normal ligaments [12, 40]. Based on the recommended 
indications about half of patients requiring knee replace-
ment can be treated with UKR, and surgeons achieving good 
results tend to use UKR for at least 20% and commonly 
50% of their knee replacements. In contrast, most surgeons 
contributing to the National Joint Registry (NJR) do small 
numbers of UKR (the commonest number is one per year) 
and use UKR for less than 10% of their knee replacements, 
often for early arthritis, which is associated with poor results 
[17, 21]. Therefore, to reflect what can be achieved with 
UKR the assessment of lifetime risk of revision should be 
based on surgeons adhering to the recommended indications 
and surgical techniques.
In the absence of a large series of UKR followed up until 
all patients have died, lifetime risk of revision can be cal-
culated based on annual revision rates and death rates in 
different age groups. Death rates can be determined from 
national statistics. Annual revision rates should be based 
on data from well documented patient series. However, 
these tend to be of limited duration so long term predictions 
are required, which can be done with parametric survival 
models. There are different models that may give higher or 
lower long-term revision rates. It is therefore useful to use 
a number of different models to assess the accuracy of the 
long-term predictions.
To help inform patients, surgeons, and health providers, 
the aim of this study was to estimate lifetime revision risk for 
patients of different ages undergoing UKR. The hypothesis 
was that the majority of young patients would undergo revi-
sion during their lifetime.
Materials and methods
Overview
A state-based Markov model was constructed with transi-
tion probabilities for revision informed from a large cohort 
of consecutive UKR and transition probabilities for mortal-
ity informed from the United Kingdom Office for National 
Statistics. This model was used to estimate the percentage 
of patients that would be revised over the course of their 
lifetime. As a sensitivity analysis, assumptions that revision 
risk would reduce after 90 years of age, and a revision rate 
from the National Joint Registry were tested.
Cohort
Between June 1998 and March 2009, 1000 consecutive 
medial meniscal bearing UKRs were carried out through a 
minimally invasive approach in 818 patients by two surgeons 
(CAFD, DWM) who were involved with the design of the 
prosthesis. All patients met the recommended indications 
as described by Goodfellow et al. [10]. The pathological 
diagnosis was bone-on-bone anteromedial osteoarthritis 
with functionally intact ligaments in 977 knees and spon-
taneous osteonecrosis of the knee in 23. The mean follow 
up of this cohort is 10 years (range 5–17). The mean age of 
the cohort at surgery was 66.6 years (SD 9.6 years, range 
33–88; Table 1). 391 knees (332 patients) had minimum 
10 years follow up. There were 52 revisions, occurring at a 
mean age of 66.3 years (SD 8, range 49–80) and mean follow 
up of 5.6 years (SD 4, range 2 months to 15 years). Twelve 
of these revisions occurred in patients younger than 60 at 
intervention. The 10-year survival was 94% (452 at risk, 
95% CI 92–96), and the 15-year survival 91% (55 at risk, 
95% CI 83–98). 118 patients died (142 knees), 36 patients 
(42 knees) withdrew from the study because of poor health, 
and three patients (four knees) were lost to follow up. This 
patient series has previously been reported in detail [31].
Patients were followed up by research physiotherapists 
independent of the surgical and clinical teams involved in 
the care of the patients. Patients were assessed pre-opera-
tively and at 1, 5, 7, 10, 12 and 15 years post-operatively. 
All patients were contacted to ascertain the incidence of 
revisions. Revision was defined in the same manner as 
the National Joint Registry [24], as component removal, 
exchange or addition. It therefore included insertion of a 
new bearing for bearing dislocation or washout, addition of 
a lateral UKR for disease progression or conversion to a total 
Table 1  Cohort demographics




N < 60 (%) 242 (24%)
N 60– < 75 (%) 552 (55%)
N 75+ (%) 206 (21%)
Mean body mass index (SD) 28.5 (5)
N female (%) 487 (49%)
Mean follow up in years (range) 10.3 (5–17)
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knee replacement (TKR). If a patient had died, information 
about the status of their knee and any further operation was 
obtained from primary and secondary care records, and from 
the patient’s relatives where appropriate.
Statistical methods
To extrapolate revision risk, a multi-state Markov model was 
constructed with three health states: ‘unrevised’, ‘revised’, 
and ‘dead’ (Fig. 1) [6]. Individuals began as unrevised and 
then remained so until death or until revised. Such a model 
reflects the competing risk nature of revision. Transition 
probabilities to ‘revised’ were informed from parametric 
regression models fitted to the cohort revision data. A num-
ber of alternative distributions for parametric models were 
fitted separately, these were exponential, Gompertz, Weibull, 
log normal, log logistic and generalised gamma distribu-
tion. The different models allow the revision risk to increase, 
decrease, or stay the same over time. Akaike’s information 
criteria (AIC) was calculated for each model as an estimator 
of the relative quality of each model. Transition probabilities 
to death were informed from the Office for National Statis-
tics (ONS) National Life Tables [29]. Subjects entered the 
model at the age of interest following their UKR. Each year, 
subjects could remain in their current health state, or transi-
tion to a new health state. Each of these transitions is repre-
sented by arrows in Fig. 1, and had a defined probability of 
occurring. The simulation was run separately for a cohort of 
1000 patients for each age of interest. Confidence intervals 
were calculated via bootstrapping, with 250 estimations.
Because of uncertainties about the generalisability of this 
study, as well as the regression models themselves, a sensi-
tivity analysis was performed to assess their effects on the 
results. The first analysis examined the lifetime risk from the 
NJR report for mobile bearing UKR. The second analysis 
tested an assumption that elderly patients are less likely to 
be offered revision due to comorbidities. For this, the risk 
of revision was halved after an arbitrarily chosen age of 90. 
For this analysis, the revision risk was modelled with an 
exponential model as this had the best fit to the data. The 
model was validated by estimating incidence rate per 100 
component years from 10 years’ worth of predictions, which 
allowed comparison to observed values from the cohort.
Statistical analyses were performed in R [34] using the 
survHE package [2].
Results
The exponential model had the best fit for estimation of 
revision probability (AIC 642.8), when compared with the 
Gompertz (AIC 644.0), Weibull (AIC 644.5), log logis-
tic (AIC 644.7), log normal (AIC 645.7), and general-
ised gamma (AIC 646.4) models. The exponential model 
predicted similar component time incidence rates to that 
observed in the cohort (Fig. 2). Therefore the exponential 
model was used for the main analysis.
The estimated lifetime revision risk increases with 
younger age at operation (Table 2; Fig. 3). The possible out-
comes in the years following surgery are shown in Fig. 4. 
Point estimates for lifetime revision risk from the expo-
nential model were 15% (95% CI 12–19), 11% (8–13), 7% 
(5–9) and 4% (3–5) for those aged 55, 65, 75 and 85 years 
at operation respectively. The uncertainty around long-term 
predictions are reflected in the large confidence intervals 
in younger patients, which decrease with older age. The 
































Observed age group / age of prediction (years)
Observed and predicted revision rates per 100 
component years at ten year follow up
Observed Predicted
Fig. 2  We predicted component time incidence rates after a 10 years 
simulation to match the mean 10  years observed follow up of this 
cohort. Predictions were very similar to observed rates
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different models produced differing estimates (Table 2). The 
variability between model point estimates from age 55 to 85 
respectively was 10% (12–22), 4.5% (10–14), 1.2% (7–8), 
and 0.1% (3.7–3.8%).
The sensitivity analyses had the following results: halv-
ing the revision rate from 90 years of age led to estimates 
of 15%, 10%, 6% and 3% respectively. Increasing the revi-
sion rate to that seen in the NJR increased the lifetime revi-
sion risk to 25%, 16%, 8% and 3% for those 55, 65, 75 and 
85 years at operation respectively.
Discussion
The most important finding of the study was that the risk 
of revision of UKR in a patient’s lifetime is low. As was 
expected, higher rates were found in younger patients. The 
youngest modelled patient age was 55, and patients of this 
age were found to have a lifetime revision risk of 15% (CI 
12–19). This reduced to a lifetime risk of 4% (CI 3–5) for 
those of 85 years of age at operation. Surgeons and patients 
will find these results encouraging, as it is widely expected 
that patients younger than 60 at operation will almost cer-
tainly require revision surgery in their lifetime. Furthermore 
this study’s hypothesis, based on the perception that the 
majority of young patients would require a revision dur-
ing their lifetime, was rejected. The graphs shown in Fig. 4 
highlight the various states that the patients may be in as 
time passes following the surgery, and demonstrate, even in 
the young how low the risk of revision actually is.
Communication of risk has become increasingly impor-
tant in patient-centred medicine [9]. As part of the consent 
process risks and benefits of intervention must be clearly 
communicated, and there is reasonable evidence to suggest 
that 5 or 10-year revision risks are difficult for patients to 
interpret. The James Lind Alliance Priority Setting Partner-
ship, a public-patient involvement group, highlighted that 
the relationship between timing of joint replacement and 
best outcome is of great importance to patients. This is a 
particular concern for young patients, as they are widely 
expected to outlive their primary joint replacement. Thus, 
if and when revision surgery may occur becomes a major 
factor in deciding whether to proceed with surgery. Lifetime 
revision risk estimates are one way of quantifying the likeli-
hood that they will outlive their prosthesis.
Lifetime revision risk has not previously been estimated 
for UKR. Burn and colleagues [5] recently looked at 10,000 
total knee replacements; and using similar predictive mod-
elling techniques predicted for patients of 50 years of age a 
34% lifetime risk of revision, dropping to about 3% for those 
undergoing TKR at age 80. Further, Evans and colleagues 
[8] undertook a long term analysis, albeit without age strat-
ification, and using data predominantly from the Finnish 
arthroplasty registry concluded that the 25 years revision 
rate was about 18% for TKR, and 30% for UKR. Bayliss and 
colleagues [3] published detailed lifetime risk estimates for 
TKR, using different methodology, based on a dataset of 
over 50,000 patients with a mean follow up of 5 years. Like 
us, they found that lifetime risk reduces with increasing age 
and in older patients the lifetime risk of revision was similar 
with UKR and TKR. Their data would suggest that at age 
55 the lifetime risk of revision was about 20% for women 
and 35% for men. This study found no significant difference 
between men and women, and found that at 55 the UKR had 
a lifetime risk of revision of about 15%. This suggests that, 
providing the UKR is used appropriately, in young women 
the lifetime risk of revision is similar in UKR and TKR, 
whereas in young men the lifetime risk may actually be less 
Table 2  Lifetime revision risk 
point estimates from different 
models (95% confidence 
interval)
UKR unicompartmental knee replacement
*The exponential distribution was used for the base-case analysis
Age at UKR 55 65 75 85
Exponential* 14.9% (12–19%) 10.7% (8–13%) 6.8% (5–9%) 3.7% (3–5%)
Gompertz 22.5% (11–55%) 14.1% (8–28%) 7.8% (5–13%) 3.8% (3–5%)
Weibull 16.2% (12–24%) 11.5% (9–17%) 7.1% (6–11%) 3.8% (3–5%)
Log logistic 15.5% (11–26%) 11.1% (8–17%) 7.0% (5–10%) 3.8% (3–5%)
Log Normal 12.5% (10–19%) 9.6% (7–14%) 6.6% (5–10%) 3.8% (3–5%)















Age at UKR (years)
Fig. 3  Estimated lifetime revision risk with 95% confidence intervals
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in UKR. Even if the lifetime risk of UKR and TKR were 
similar UKR would be advantageous because revision is 
simpler and is usually a conversion to a TKR [36]. Further-
more UKR provide better PROMs [20], lower morbidity and 
mortality [19] and a faster recovery [7].
Young age is considered to increase the risk of revision 
as their relatively higher activity levels place increased 
mechanical loads and wear on the implant and bone-implant 
interface. In this context, when compared to TKR, menis-
cal-bearing UKR has theoretical reasons for reducing the 
revision rate. The fully congruent bearing has low contact 
stresses, which minimises linear wear and the risk of the 
replacement wearing out [11, 37]. It also transmits predomi-
nately compressive forces to the bone-implant interfaces, 
which minimises the risk of loosening [29]. Furthermore, 
the instrumentation aims to restore ligament tension and 
function [29], thereby restoring normal knee kinematics 
[32]. In the observed cohort, the youngest patients have 
the lowest risk of revision due to disease progression [16]. 
Although this may seem counterintuitive, it suggests that 
younger patients may have better quality retained cartilage 
and bone, and are less likely to fail from lateral osteoarthritis 
or aseptic loosening, which represent the two main modes of 
UKR failure. These factors all tend to decrease the revision 
rate of UKR compared to TKR resulting in the lifetime risk 
of revision being similar, or perhaps even better in young 
men who are the most likely to destroy knee replacements.
Many surgeons feel TKR is the best procedure in the 
elderly, as TKR will not require a revision whereas UKR 
may. However, as the life expectancy is relatively short in 
the elderly the lifetime risk of a revision of a UKR is very 
low (4% at age 85, Fig. 4), and only slightly higher than 
TKR [3], so other factors need to be considered. In the 
elderly the rapid recovery, and lower incidence of major 
Fig. 4  Graphical representa-
tion of the competing risk of 
death and revision in patients of 
different age groups. Note the 
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Transion states for paents undergoing UKR at 85 years of 
age
Alive & unrevised Revised (alive) Revised (dead) Dead
 Knee Surgery, Sports Traumatology, Arthroscopy
1 3
medical complications and death are major advantages of 
UKR [15, 19]. In a matched study of over 100,000 knee 
replacements, it has been shown that, with UKR com-
pared to TKR, the risk of major medical complications 
more than halved and, in the first 3 months following sur-
gery, the risk of death is about 50% less, and over 4 years 
it is about 25% less [19]. In the elderly the background 
risk of medical problems and death is high, therefore the 
decreased risk of medical complications and death will far 
outweigh the slightly increased lifetime risk of revision.
There are limitations of the study: the use of a designer 
centre series where all patients met established indications 
to inform revision risk, limits its generalisability. How-
ever, in multiple studies it has been shown that provided 
surgeons use the recommended indications and therefore 
use UKR for at least 20% of knee replacements they will 
have similar revision rates to the designer centre [1, 14, 
22, 23, 33, 42]. Therefore the results are likely to be gen-
eralisable to surgeons using the recommend indications. 
Further, a recent randomised controlled trial, assessed the 
results from 68 surgeons across 27 centres in the United 
Kingdom, and found identical revision rates at 5 years for 
UKR and TKR [4]. As part of the sensitivity analysis the 
lifetime revision risk was modelled based on data reported 
in the NJR, and whilst these estimates were higher, as low 
volume surgeons who may be using inappropriate indica-
tions are included, there was still only a 25% lifetime revi-
sion risk in those 55 years of age, which is substantially 
lower than what many would expect.
Although the dataset was substantially smaller (1000 
patients) than Bayliss’, it had double the mean follow up 
(10 years) and modelled the revision hazard with para-
metric survival methods, allowing estimation of revision 
risk beyond the observed data and the construction of a 
Markov model. Calculated component time incidence rates 
at 10-year follow up were almost identical estimates to the 
observed data at all ages except the very young (55 years) 
(Fig. 2). In the very young the revision rate in the model 
(0.6% per year) was higher than the observed data (0.4% 
per year), which suggests that in the young there is a con-
servative estimate of the revision rate and therefore of the 
lifetime risk. The results were only slightly influenced by 
the different parametric models (Table 2), which model 
the revision rate increasing or decreasing in the long term 
suggesting that the conclusions are robust.
In conclusion, these estimates of lifetime risk of revi-
sion will help patients and surgeons in their decision making 
process about whether to receive a medial meniscal-bearing 
UKR. They support the use of UKR as a definitive prosthesis 
in all age groups provided it is used for the recommended 
indications.
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